Personalizing cancer care demands the right tools in order to get patients the right treatment at the right time. Our integrated value chain of precision oncology tools equips theranostics programs with state-of-the-art solutions at every step of the theranostics care pathway.
Theranostics for personalized
cancer care
Empowering precision oncology
cancer care
Did this information help you?
World Health Organization. Worldwide cancer data. Available at https://www.wcrf.org/dietandcancer/worldwide-cancer-data/.
United Nations. UN projects world population to reach 8.5 billion by 2030, driven by growth in developing countries. Available at https://www.un.org/sustainabledevelopment/blog/2015/07/un-projects-world-population-to-reach-8-5-billion-by-2030-driven-by-growth-in-developing-countries/.
Yordanova A, et al. Theranostics in nuclear medicine practice. Onco Targets Ther. 2017;10:4821-4828. doi:10.2147/OTT.S140671.
Baum RP, et al. 177Lu-Labeled Prostate-Specific Membrane Antigen Radioligand Therapy of Metastatic Castration-Resistant Prostate Cancer: Safety and Efficacy. J Nucl Med. 2016;57(7):1006-13. doi:10.2967/jnumed.115.168443.
syngo.via can be used as a standalone device or together with a variety of syngo.via-based software options which are medical devices in their own right.
syngo.via and the syngo.via-based software options are not commercially available in all countries. Due to regulatory reasons their future availability cannot be guaranteed.
Please contact your local Siemens Healthineers organization for further details.
This feature is under development and is not commercially available for sale. Future availability cannot be guaranteed.
Syngo Carbon consists of several products which are (medical) devices in their own right. Some products are under development and not commercially available. Future availability cannot be guaranteed.
Lutetium oxyorthosilicate.
The amount of metal artifact reduction and corresponding improvement in image quality depends on a number of factors including: composition and size of the metal object, patient size, anatomical location and clinical practice. It is recommended to perform reconstruction with iMAR enabled in addition to conventional reconstruction without iMAR.
Compared to current state-of-the-art scanners at time of publication. Data on file.
Every Symbia Pro.specta configuration produces the highest image quality in its class. Based on competitive literature available at time of publication. Data on file.
Abdomen Dot Engine Workflow Study from Zhongshang Hospital, Fudan University, Shanghai, China.
Herrmann K, et al. Joint EANM, SNMMI and IAEA enabling guide: how to set up a theranostics centre. Eur J Nucl Med Mol Imaging. 2022;49(7):2300-2309. doi:10.1007/s00259-022-05785-x.
The products and features (mentioned herein) are not commercially available in all countries. Future availability cannot be guaranteed.
Header image data courtesy of New York-Presbyterian Hospital/Weill Cornell Medical Center, New York, New York, USA.